Anixa Biosciences (ANIX) Competitors

Anixa Biosciences (NASDAQ:ANIX) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, community ranking, media sentiment, dividends, institutional ownership, valuation and profitability.

Do institutionals and insiders hold more shares of ANIX or ENZ?

29.1% of Anixa Biosciences shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 22.6% of Anixa Biosciences shares are owned by insiders. Comparatively, 15.5% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer ANIX or ENZ?

Enzo Biochem received 194 more outperform votes than Anixa Biosciences when rated by MarketBeat users. However, 64.29% of users gave Anixa Biosciences an outperform vote while only 56.53% of users gave Enzo Biochem an outperform vote.

Company	Underperform	Outperform
Anixa Biosciences	Outperform Votes 18 64.29%	Underperform Votes 10 35.71%
Enzo Biochem	Outperform Votes 212 56.53%	Underperform Votes 163 43.47%

Which has more volatility and risk, ANIX or ENZ?

Anixa Biosciences has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

Is ANIX or ENZ more profitable?

Enzo Biochem has a net margin of 99.28% compared to Anixa Biosciences' net margin of 0.00%. Enzo Biochem's return on equity of -36.71% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anixa Biosciences	N/A	-49.27%	-45.55%
Enzo Biochem	99.28%	-36.71%	-22.29%

Does the media prefer ANIX or ENZ?

In the previous week, Anixa Biosciences had 8 more articles in the media than Enzo Biochem. MarketBeat recorded 8 mentions for Anixa Biosciences and 0 mentions for Enzo Biochem. Anixa Biosciences' average media sentiment score of 1.35 beat Enzo Biochem's score of 0.00 indicating that Anixa Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Anixa Biosciences	Positive
Enzo Biochem	Neutral

Which has higher earnings and valuation, ANIX or ENZ?

Enzo Biochem has higher revenue and earnings than Anixa Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anixa Biosciences	$210K	388.69	-$9.81M	-$0.37	-6.89
Enzo Biochem	$31.06M	1.86	$20.29M	N/A	N/A

Do analysts recommend ANIX or ENZ?

Anixa Biosciences currently has a consensus price target of $12.00, suggesting a potential upside of 370.59%. Given Anixa Biosciences' higher possible upside, equities research analysts plainly believe Anixa Biosciences is more favorable than Enzo Biochem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Enzo Biochem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Anixa Biosciences beats Enzo Biochem on 8 of the 15 factors compared between the two stocks.